FOXNews.com: Galenica's kidney drug meets endpoint in trial

FOXNews.com FOX News Network - We Report. You Decide.

Galenica's kidney drug meets endpoint in trial Jul 9th 2012, 11:50 Swiss healthcare company Galenica said on Monday that its kidney drug PA21 successfully met primary and secondary endpoints in a late-stage trial

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions